Aventria Health Group
The IRA Provisions: It’s NOT Business as Usual
Peter Neumann, CEVR director, discussed CMS drug negotiation provisions in the IRA and implications on a Relentless Health Value™ podcast.
top of page
Search
Aventria Health Group
- Apr 20
- 3 min
Unlock the Power of an Aventria Executive ThinkTank™ to Prepare for the IRA
The IRA creates a game-changing set of considerations and imperatives for Pharma and the healthcare system. An Aventria Executive ThinkTank™
Aventria Health Group
- May 27, 2022
- 3 min
Medicare Advantage Growth = Opportunities for Pharma to Support Patient Care
The Centers for Medicare & Medicaid Services (CMS) is transforming payment, delivery, and care in Medicare Advantage (MA) policies.
Blog Archive
bottom of page